Skip to main content

Genomics England one of 2014’s 50 Smartest Companies

Genomics England has been recognised as one of 2014’s 50 Smartest Companies in MIT Technology Review’s annual list of the world’s most innovative technology companies.

The companies honoured are nominated by MIT Technology Review’s editors, who look for companies that have demonstrated original and valuable technology over the last year, are bringing that technology to market at significant scale, and are clearly influencing their competitors.

At times it seems impossible to keep pace with important emerging technologies. We are therefore celebrating organisations at the forefront, displaying ‘disruptive innovation’ that will surpass the competition, transform an industry and change our lives

Jason Pontin

Publisher and Editor-in-Chief of MIT Technology Review

Genomics England is a wholly owned by the Department of Health and was launched in July 2013 to bring the potential of whole genome sequencing of DNA to the National Health Service.

Its mission is to sequence the whole DNA of NHS patients with cancer or a rare disease, sequencing 100,000 genomes by 2017 and making the data available for research and development.

We are very pleased to have received this award. The United Kingdom has always been at the forefront of innovation, including in seeking medical breakthroughs, so it is fitting that Genomics England has been honoured in this way.

We acknowledge the vision of the Prime Minister and the Secretary of State in pushing forward with an initiative that had been discussed within academia for some time

Sir John Chisholm

Executive Chairman of Genomics England

Genomics England and the other honorees will be featured in the March/April edition of MIT Technology Review, published online and available on newsstands worldwide from March 4.

MIT Technology Review leads the global conversation about technologies that matter. An independent media company owned by Massachusetts Institute of Technology in Cambridge, MA, it produces publications read by millions of business leaders, innovators, and thought leaders around the globe, in six languages and on a variety of platforms.

Media contact

[email protected]

Follow us

Get the latest updates straight to your inbox